Lynette Sholl
@lmsholl
Followers
425
Following
50
Statuses
67
Joined September 2015
RT @DrSteveMartin: Please see below short outline of emerging biomarkers in cancer management- can you keep up? Maybe we can help along wi…
0
3
0
@emilyschmall Emily, nice article, but check the stats on mucor rates in US and Europe. Hard to get a solid number but immunocompromized patients at risk regardless of geography.
1
0
0
RT @ModernPathology: ⭐New #ModPathChat! Ep 4/4 Special Edition #USCAP2021 Long Course: Pulmonary Pathology Dr. @lmsholl discusses w @DrNe…
0
8
0
RT @DrSteveMartin: Dizzy from all brand new FDA approvals? Might be opportune time to invite u to our ICOP meeting along w @lmsholl where…
0
8
0
RT @HMSPostgradCE: Molecular Diagnostics: Current Roles in Cancer Diagnosis and Patient Management will review up-to-date techniques in mol…
0
3
0
This is not exactly how mTB looks under the microscope... maybe we need to replace our mycobacterial stains @JLHornick @damilnermd >> CDC investigating TB cases linked to tainted bone repair product used in more than 100 patients
0
0
5
@villalba_julian @infectio01 @FranciscoMarty_ I know, Julian. I’m just so sad and in a state of disbelief.
0
0
0
RT @infectio01: My best friend , mentor , photographer extraordinaire. I will miss you every day until we meet again . I will need to be ve…
0
7
0
RT @BrJCancer: Digital Imaging Calls for Papers - open for submissions. Guest Editors: Lynette Sholl and Rulla Tamimi @lmsholl @rtamimi Fo…
0
1
0
A big shout out to Suma Thomas and colleagues at CCF: Vitamins won’t make your Covid better. Prevention is the best medicine. Mask! Vaccinate!! Effect of Zinc and Ascorbic Acid on Symptom Length Among Patients With SARS-CoV-2 @ClevelandClinic
0
1
4
@natasharekhtman @alexdrilon @RobinGuo5 @ahmetz @RymaBenayed @deepualexmd @charlesrudin @Sinchita_Roy @MSKPathology Very interesting study- goes to show don’t throw the baby out with the bath water. Question is specificity of high met expression as a predictor of met inhibitor response if one doesn’t know the ex14 status.
1
0
5
Site-Specific and Targeted Therapy Based on Molecular Profiling for Cancer of Unknown Primary Site via @JAMAOnc part of @JAMANetwork — highlighting the clinical relevance of genomic profiling in patients with cancers of unknown primary
0
8
18